Assessment of damage in Korean patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 34, Issue 5, 2007, Pages 987-991

  Sung, Yoon Kyoung ^a   Nam, Wook Hur ^a   Jina, Lee Sinskey ^a   Park, Dawon ^a   Bae, Sang Cheol ^a,b  

^a Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^b Hanyang University Medical Center   (South Korea)

Author keywords

Damage; Risk factors; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; STEROID;

ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EYE DISEASE; FEMALE; HUMAN; KOREA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; MUSCULOSKELETAL SYSTEM; NEUROPSYCHIATRY; ONSET AGE; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RISK FACTOR; STUDENT T TEST; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY TRACT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COMORBIDITY; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KOREA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34248652915     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Trager J, Ward MM. Mortality and causes of death in systemic lupus erythematosus. Curr Opin Rheumatol 2001;13:345-51.
2. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
3. Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 2001;10:93-6.
4. Alarcon GS, Roseman JM, McGwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. Rheumatology Oxford 2004;43:202-5.
5. Alarcon GS, McGwin G Jr, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001;44:2797-806.
6. Toloza SM, Roseman JM, Alarcon GS, et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXII. Predictors of time to the occurrence of initial damage. Arthritis Rheum 2004;50:3177-86.
7. Stoll T, Sutcliffe N, Klaghofer R, Isenberg DA. Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study. Ann Rheum Dis 2000;59:832-5.
8. Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus - a 5-yr prospective study. Rheumatology Oxford 2004;43:1039-44.
9. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000;43:1801-8.
10. Zonana-Nacach A, Camargo-Coronel A, Yanez P, et al. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration. Lupus 1998;7:119-23.
11. Mok CC, Ho CT, Wong RW, Lau CS. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2003;30:1513-9.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
13. Gladman DD, Urowitz MB, Rahman P, Ibanez D, Tam LS. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1955-9.
14. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C. Association of damage with autoantibody profile, age, race, gender and disease duration in systemic lupus erythematosus. Rheumatology Oxford 2003;42:276-9.
15. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:47-56.
16. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum 1995;38:274-83.
17. Rivest C, Lew RA, Welsing PM, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 2000;27:680-4.
18. Sundaramurthy S, Bush TM, Neuwelt CM, Ward MM. Time perspective predicts the progression of permanent organ damage in patients with systemic lupus erythematosus. Lupus 2003;12:443-8.
19. Ravelli A, Duarte-Salazar C, Buratti S, et al. Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study. Arthritis Rheum 2003;49:501-7.
20. Sutcliffe N, Clarke AE, Gordon C, Farewell V, Isenberg DA. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology Oxford 1999;38:1130-7.
21. Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A, Ugalde J, Aguirre C. Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus. Lupus 2004;13:900-5.
22. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology Oxford 2004;43:1555-60.
23. Prasad R, Ibanez D, Gladman D, Urowitz M. Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus. Lupus 2006;15:285-91.